| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial.
|
Lancet
|
2002
|
11.02
|
|
2
|
Tenofovir-based preexposure prophylaxis for HIV infection among African women.
|
N Engl J Med
|
2015
|
9.20
|
|
3
|
Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial.
|
Lancet
|
2008
|
7.93
|
|
4
|
Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial.
|
Lancet
|
2007
|
7.22
|
|
5
|
Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission.
|
N Engl J Med
|
2008
|
6.00
|
|
6
|
Short-course antiretroviral therapy in primary HIV infection.
|
N Engl J Med
|
2013
|
4.82
|
|
7
|
Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
|
Lancet HIV
|
2015
|
4.33
|
|
8
|
PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial.
|
Lancet
|
2010
|
3.90
|
|
9
|
Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women.
|
AIDS
|
2011
|
2.86
|
|
10
|
Microbicide acceptability research: current approaches and future directions.
|
Soc Sci Med
|
2005
|
2.54
|
|
11
|
Incidence of HIV-1 dual infection and its association with increased viral load set point in a cohort of HIV-1 subtype C-infected female sex workers.
|
J Infect Dis
|
2004
|
2.29
|
|
12
|
Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa.
|
J Virol
|
2002
|
1.97
|
|
13
|
Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections: systematic review and meta-analysis of randomised controlled trials including more than 5000 women.
|
Lancet Infect Dis
|
2002
|
1.88
|
|
14
|
Assessing the reporting of adherence and sexual activity in a simulated microbicide trial in South Africa: an interview mode experiment using a placebo gel.
|
AIDS Behav
|
2011
|
1.68
|
|
15
|
Characterization and selection of HIV-1 subtype C isolates for use in vaccine development.
|
AIDS Res Hum Retroviruses
|
2003
|
1.68
|
|
16
|
Hormonal contraception and the risk of HIV acquisition among women in South Africa.
|
AIDS
|
2012
|
1.41
|
|
17
|
Appropriateness of hydroxyethylcellulose gel as a placebo control in vaginal microbicide trials: a comparison of the two control arms of HPTN 035.
|
J Acquir Immune Defic Syndr
|
2013
|
1.33
|
|
18
|
Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women.
|
Sex Transm Dis
|
2010
|
1.29
|
|
19
|
Combined impact of sexual risk behaviors for HIV seroconversion among women in Durban, South Africa: implications for prevention policy and planning.
|
AIDS Behav
|
2011
|
1.28
|
|
20
|
The effects of injectable hormonal contraceptives on HIV seroconversion and on sexually transmitted infections.
|
AIDS
|
2012
|
1.26
|
|
21
|
Provision of antiretroviral therapy in South Africa: unique challenges and remaining obstacles.
|
J Infect Dis
|
2007
|
1.20
|
|
22
|
Novel strategies implemented to ensure high participant retention rates in a community based HIV prevention effectiveness trial in South Africa and Zimbabwe.
|
Contemp Clin Trials
|
2009
|
1.15
|
|
23
|
Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy.
|
PLoS One
|
2013
|
1.11
|
|
24
|
"We have our protector": misperceptions of protection against HIV among participants in a microbicide efficacy trial.
|
Am J Public Health
|
2006
|
1.09
|
|
25
|
Acceptability and use of the diaphragm and Replens lubricant gel for HIV prevention in Southern Africa.
|
AIDS Behav
|
2009
|
1.08
|
|
26
|
The relationship between age of coital debut and HIV seroprevalence among women in Durban, South Africa: a cohort study.
|
BMJ Open
|
2012
|
1.07
|
|
27
|
The impact of the use of COL-1492, a nonoxynol-9 vaginal gel, on the presence of cervical human papillomavirus in female sex workers.
|
Virus Res
|
2006
|
1.07
|
|
28
|
Longitudinal analysis of HIV type 1 subtype C envelope sequences from South Africa.
|
AIDS Res Hum Retroviruses
|
2007
|
1.06
|
|
29
|
Patterns and predictors of adherence to diaphragm use in a phase III trial in sub-Saharan Africa: a trajectory analysis.
|
J Acquir Immune Defic Syndr
|
2009
|
1.05
|
|
30
|
Geoadditive models to assess spatial variation of HIV infections among women in local communities of Durban, South Africa.
|
Int J Health Geogr
|
2011
|
1.05
|
|
31
|
Male circumcision for HIV prevention: clinical practices and attitudes among healthcare providers in South Africa and Zimbabwe.
|
Sex Transm Dis
|
2012
|
1.03
|
|
32
|
Carraguard Vaginal Gel Safety in HIV-Positive Women and Men in South Africa.
|
J Acquir Immune Defic Syndr
|
2007
|
1.02
|
|
33
|
The use of the diaphragm instead of condoms in a phase III diaphragm trial.
|
AIDS Behav
|
2008
|
1.00
|
|
34
|
Prevalence of HIV-1 drug resistance among women screening for HIV prevention trials in KwaZulu-Natal, South Africa (MTN-009).
|
PLoS One
|
2013
|
0.99
|
|
35
|
The effectiveness of Carraguard, a vaginal microbicide, in protecting women against high-risk human papillomavirus infection.
|
Antivir Ther
|
2011
|
0.98
|
|
36
|
African women recently infected with HIV-1 and HSV-2 have increased risk of acquiring Neisseria gonorrhoeae and Chlamydia trachomatis in the Methods for Improving Reproductive Health in Africa trial.
|
Sex Transm Dis
|
2011
|
0.97
|
|
37
|
Ethical considerations in determining standard of prevention packages for HIV prevention trials: examining PrEP.
|
Dev World Bioeth
|
2013
|
0.96
|
|
38
|
High-risk human papillomavirus is associated with HIV acquisition among South African female sex workers.
|
Infect Dis Obstet Gynecol
|
2011
|
0.96
|
|
39
|
Bacterial vaginosis and the risk of trichomonas vaginalis acquisition among HIV-1-negative women.
|
Sex Transm Dis
|
2014
|
0.96
|
|
40
|
Risk factors for incidence of sexually transmitted infections among women in South Africa, Tanzania, and Zambia: results from HPTN 055 study.
|
Sex Transm Dis
|
2009
|
0.96
|
|
41
|
User experiences and acceptability attributes of the diaphragm and lubricant gel in an HIV prevention trial in southern Africa.
|
AIDS Care
|
2011
|
0.95
|
|
42
|
Contraception use and effectiveness among women in a trial of the diaphragm for HIV prevention.
|
Contraception
|
2011
|
0.92
|
|
43
|
Willingness of clinicians to integrate microbicides into HIV prevention practices in southern Africa.
|
AIDS Behav
|
2012
|
0.92
|
|
44
|
Mucosal Escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial.
|
J Infect Dis
|
2012
|
0.92
|
|
45
|
Microbicide acceptability: insights for future directions from providers and policy makers.
|
AIDS Educ Prev
|
2008
|
0.91
|
|
46
|
Assessing and evaluating the combined impact of behavioural and biological risk factors for HIV seroconversion in a cohort of South African women.
|
AIDS Care
|
2012
|
0.90
|
|
47
|
Incidence of Sexually Transmitted Infections among HIV-positive sex workers in KwaZulu-Natal, South Africa.
|
Sex Transm Dis
|
2002
|
0.89
|
|
48
|
High prevalence of obesity among women who enrolled in HIV prevention trials in KwaZulu-Natal, South Africa: healthy diet and life style messages should be integrated into HIV prevention programs.
|
BMC Public Health
|
2013
|
0.89
|
|
49
|
Effects of partnership change on microbicide gel adherence in a clinical trial (HPTN 035).
|
AIDS Behav
|
2014
|
0.88
|
|
50
|
The current status of the use of oral medication to prevent HIV transmission.
|
Curr Opin HIV AIDS
|
2015
|
0.88
|
|
51
|
Determinants of differential HIV incidence among women in three southern African locations.
|
J Acquir Immune Defic Syndr
|
2011
|
0.87
|
|
52
|
Intimate partner violence and condom and diaphragm nonadherence among women in an HIV prevention trial in southern Africa.
|
J Acquir Immune Defic Syndr
|
2013
|
0.86
|
|
53
|
HIV-1 seroconversion promotes rapid changes in cervical human papillomavirus (HPV) prevalence and HPV-16 antibodies in female sex workers.
|
J Med Virol
|
2009
|
0.86
|
|
54
|
Diaphragm and lubricant gel acceptance, skills and patterns of use among women in an effectiveness trial in Southern Africa.
|
Eur J Contracept Reprod Health Care
|
2009
|
0.85
|
|
55
|
Age-Disparate Partnerships and Risk of HIV-1 Acquisition Among South African Women Participating in the VOICE Trial.
|
J Acquir Immune Defic Syndr
|
2015
|
0.83
|
|
56
|
The effect of the vaginal diaphragm and lubricant gel on acquisition of HSV-2.
|
Sex Transm Infect
|
2011
|
0.83
|
|
57
|
A nationally representative survey of healthcare provider counselling and provision of the female condom in South Africa and Zimbabwe.
|
BMJ Open
|
2013
|
0.81
|
|
58
|
Impact of learning HIV status on contraceptive use in the MIRA trial.
|
J Fam Plann Reprod Health Care
|
2011
|
0.80
|
|
59
|
Efficacy of an alcohol-focused intervention for improving adherence to antiretroviral therapy (ART) and HIV treatment outcomes - a randomised controlled trial protocol.
|
BMC Infect Dis
|
2014
|
0.79
|
|
60
|
Heterosexual transmission of multiple highly conserved viral variants in HIV-1 subtype C-infected seronegative women.
|
AIDS
|
2004
|
0.78
|
|
61
|
Changes in sexual risk behavior before and after HIV seroconversion in Southern African women enrolled in a HIV prevention trial.
|
J Acquir Immune Defic Syndr
|
2011
|
0.78
|
|
62
|
High risk sexual behaviors are associated with sexual violence among a cohort of women in Durban, South Africa.
|
BMC Res Notes
|
2013
|
0.77
|
|
63
|
Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV Infection.
|
J Acquir Immune Defic Syndr
|
2016
|
0.77
|
|
64
|
Utility of colposcopy in a phase 2 portion of a microbicide clinical trial of BufferGel and 0.5% PRO 2000 Gel.
|
J Int AIDS Soc
|
2012
|
0.76
|
|
65
|
Analyzing continuous measures in HIV prevention research using semiparametric regression and parametric regression models: how to use data to get the (right) answer?
|
AIDS Behav
|
2012
|
0.76
|
|
66
|
Response to Brown et al., 'Incident and prevalent herpes simplex virus type 2 infection increases risk of HIV acquisition among women in Uganda and Zimbabwe'.
|
AIDS
|
2007
|
0.75
|
|
67
|
A developing country response to Lavery et al. "In global health research, is it legitimate to stop clinical trials early on account of their opportunity costs?".
|
BMC Med Ethics
|
2009
|
0.75
|
|
68
|
Mean Corpuscular Volume as a Marker for Adherence to Zidovudine-Containing Therapy in HIV-Infected Adults.
|
Open AIDS J
|
2012
|
0.75
|
|
69
|
Evaluating HIV prevention efforts using semiparametric regression models: results from a large cohort of women participating in an HIV prevention trial from KwaZulu-Natal, South Africa.
|
J Int AIDS Soc
|
2013
|
0.75
|
|
70
|
To tell or not to tell: male partner engagement in a Phase 3 microbicide efficacy trial in South Africa.
|
Cult Health Sex
|
2015
|
0.75
|
|
71
|
Notes on the frequency of routinely collected and self-reported behavioral data in HIV prevention trials.
|
AIDS Behav
|
2011
|
0.75
|